Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AVA6000 |
Trade Name | |
Synonyms | AVA 6000|AVA-6000 |
Drug Descriptions |
AVA6000 consists of a doxorubicin molecule covalently linked to a dipeptide that can be hydrolyzed by fibroblast activation protein alpha (FAP), potentially leading to release of doxorubicin in the tumor microenvironment and inhibition of tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 1815). |
DrugClasses | Chemotherapy - Anthracycline 13 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AVA6000 | AVA6000 | 0 | 1 |